Audit Report
Tianjian Audit [2026] No. 1133
To: Zhejiang Tianyu Pharmaceutical Co., Ltd.
1. Audit Opinion
We have audited the financial statements of Shanghai Xingke High-Purity Solvent Co., Ltd. (hereinafter referred to as Xingke Solvent Company), including the consolidated and parent company balance sheets as of January 31, 2026, and December 31, 2025, the consolidated and parent company income statements for January 2026 and the year 2025, the consolidated and parent company cash flow statements, the consolidated and parent company statements of changes in equity, and the related notes to the financial statements. We believe that the attached financial statements are prepared in accordance with the provisions of enterprise accounting standards in all material respects and fairly reflect the financial position of Xingke Solvent Company as of January 31, 2026, and December 31, 2025, as well as the operational results and cash flows for January 2026 and the year 2025.
2. Basis for Audit Opinion
We conducted our audit in accordance with the auditing standards for certified public accountants in China. The section "Responsibilities of Certified Public Accountants for the Audit of Financial Statements" in the audit report further elaborates on our responsibilities under these standards. In accordance with the "Independence Standards for Certified Public Accountants No. 1 - Requirements for Independence in Financial Statement Audits and Reviews" and the Code of Ethics for Certified Public Accountants in China, we are independent of Xingke Solvent Company and have fulfilled our other ethical responsibilities. We believe that the audit evidence we obtained is sufficient and appropriate to provide a basis for our audit opinion.
3. Responsibilities of Management and Governance for the Financial Statements
The management of Xingke Solvent Company (hereinafter referred to as management) is responsible for the preparation of the financial statements in accordance with the provisions of enterprise accounting standards, ensuring that they are fairly presented, and designing, implementing, and maintaining necessary internal controls to prevent material misstatements in the financial statements due to fraud or error. In preparing the financial statements, management is responsible for assessing the company's ability to continue as a going concern, disclosing matters related to going concern (if applicable), and using the going concern assumption unless liquidation, cessation of operations, or other realistic alternatives are planned. The governance body of Xingke Solvent Company (hereinafter referred to as governance) is responsible for overseeing the financial reporting process of the company.